The last announcement provides a clue Biosignal Limited (ASX: BOS) is now in receipt of certain commercial proposals that it is reviewing which are likely to necessitate a change in management.
something's in the wind
BOS Price at posting:
2.9¢ Sentiment: Hold Disclosure: Held
